Wordt geladen...
The journey to understanding incretin systems: Theory, practice and more theory
Accumulating clinical data on incretin‐based dipeptidyl peptidase‐4 inhibitors and glucagon‐like peptide‐1 receptor agonists in the past decade have clearly confirmed their safety and efficacy as antidiabetes drugs. However, the journey to understand the incretin system and its role in health and di...
Bewaard in:
| Gepubliceerd in: | J Diabetes Investig |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717807/ https://ncbi.nlm.nih.gov/pubmed/31361402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13123 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|